207 related articles for article (PubMed ID: 19561638)
21. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome.
Maggi LB; Kuchenruether M; Dadey DY; Schwope RM; Grisendi S; Townsend RR; Pandolfi PP; Weber JD
Mol Cell Biol; 2008 Dec; 28(23):7050-65. PubMed ID: 18809582
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of nucleophosmin induces S-phase arrest in HepG2 cells.
Wang QQ; Zhang ZY; Xiao JY; Yi C; Li LZ; Huang Y; Yun JP
Chin J Cancer; 2011 Dec; 30(12):853-60. PubMed ID: 22098949
[TBL] [Abstract][Full Text] [Related]
23. The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma.
Mascaux C; Bex F; Martin B; Burny A; Haller A; Paesmans M; Willard-Gallo K; Ninane V; Sculier JP
Eur Respir J; 2008 Sep; 32(3):678-86. PubMed ID: 18480108
[TBL] [Abstract][Full Text] [Related]
24. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.
Sugimoto M; Kuo ML; Roussel MF; Sherr CJ
Mol Cell; 2003 Feb; 11(2):415-24. PubMed ID: 12620229
[TBL] [Abstract][Full Text] [Related]
25. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2.
Nitta RT; Smith CL; Kennedy BK
PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
[TBL] [Abstract][Full Text] [Related]
27. ARF tumor suppression in the nucleolus.
Maggi LB; Winkeler CL; Miceli AP; Apicelli AJ; Brady SN; Kuchenreuther MJ; Weber JD
Biochim Biophys Acta; 2014 Jun; 1842(6):831-9. PubMed ID: 24525025
[TBL] [Abstract][Full Text] [Related]
28. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
Li Z; Boone D; Hann SR
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
[TBL] [Abstract][Full Text] [Related]
29. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.
Wang W; Budhu A; Forgues M; Wang XW
Nat Cell Biol; 2005 Aug; 7(8):823-30. PubMed ID: 16041368
[TBL] [Abstract][Full Text] [Related]
30. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
Chen D; Yoon JB; Gu W
Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
[TBL] [Abstract][Full Text] [Related]
31. B23 and ARF: friends or foes?
Lindström MS; Zhang Y
Cell Biochem Biophys; 2006; 46(1):79-90. PubMed ID: 16943625
[TBL] [Abstract][Full Text] [Related]
32. GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.
Lee S; Cho YE; Kim SH; Kim YJ; Park JH
Oncotarget; 2017 Mar; 8(10):16293-16302. PubMed ID: 27323397
[TBL] [Abstract][Full Text] [Related]
33. Nucleophosmin and human cancer.
Lim MJ; Wang XW
Cancer Detect Prev; 2006; 30(6):481-90. PubMed ID: 17113241
[TBL] [Abstract][Full Text] [Related]
34. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.
Okuda M; Horn HF; Tarapore P; Tokuyama Y; Smulian AG; Chan PK; Knudsen ES; Hofmann IA; Snyder JD; Bove KE; Fukasawa K
Cell; 2000 Sep; 103(1):127-40. PubMed ID: 11051553
[TBL] [Abstract][Full Text] [Related]
35. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N
Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538
[TBL] [Abstract][Full Text] [Related]
36. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
[TBL] [Abstract][Full Text] [Related]
37. The Myc-nucleophosmin-ARF network: a complex web unveiled.
Li Z; Hann SR
Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
[TBL] [Abstract][Full Text] [Related]
38. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
Moulin S; Llanos S; Kim SH; Peters G
Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
[TBL] [Abstract][Full Text] [Related]
39. Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer.
Barton MC; Akli S; Keyomarsi K
J Cell Physiol; 2006 Dec; 209(3):686-94. PubMed ID: 17001684
[TBL] [Abstract][Full Text] [Related]
40. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
